Illuminating the
Future of Neonatal Care
Advanced, accessible phototherapy designed to treat neonatal jaundice safely and effectively. Powered by microcontroller precision and high-intensity blue LEDs to bridge the gap in global healthcare.
Target Irradiance
50 µW/cm²/nm
The Motivation
Addressing a Critical Global Need
Neonatal jaundice is a common condition, yet effective treatment remains inaccessible in many parts of the world due to cost and complexity.
Newborns Affected
Of all newborns globally develop clinical jaundice within the first week of life.
Severe Cases
Risk developing severe hyperbilirubinemia, leading to kernicterus if untreated.
Accessibility Gap
Lack of functional devices in low-resource settings prevents timely treatment.
Why Current Solutions Fall Short
Traditional phototherapy units are often ill-suited for the environments that need them most.
Prohibitive Cost
Hospital-grade units cost thousands of dollars, making them unaffordable for rural clinics.
Power Dependency
Reliance on stable high-voltage electrical grids makes deployment difficult in developing areas.
Limited Portability
Bulky, heavy designs prevent easy transport to remote health centers.
Precision Engineering
for Safer Care
The Luminosa device utilizes a novel arrangement of components to maximize therapeutic efficacy while minimizing power consumption and heat generation.
High-Intensity Blue LEDs
3W LEDs calibrated to the optimal 450-470nm spectrum for maximum bilirubin breakdown efficiency.
4-Sided Illumination
Uniform light distribution ensures total body coverage, reducing treatment duration significantly.
Active Thermal Monitoring
Integrated sensors and microcontroller logic prevent overheating, ensuring infant safety at all times.
Microcontroller Logic
Intelligent control loop adjusts LED intensity based on ambient temperature and battery levels.
Projected Impact
By combining efficiency with accessibility, Luminosa aims to drastically improve outcomes for newborns in underserved regions.
Reduced Duration
Higher irradiance means shorter hospital stays for infants and mothers.
Neuro-Protection
Early intervention significantly lowers the risk of permanent brain damage.
Energy Efficiency
Low power requirements allow for operation via solar or battery backup.
Global Access
Designed for reproducibility and low-cost manufacturing.